Post by Improzo

Are pharma companies over-investing in black box SaaS platforms when the real opportunity lies somewhere else? In this new video, Inderpreet Kambo breaks down a question many pharma and biotech leaders are actively struggling with right now: Should companies continue investing in large SaaS programs, or is it time to rethink how work actually gets done? - Instead of focusing on what to cancel, the conversation shifts toward something much more practical: ' Which workflows are now ready to become faster, smarter, and more scalable through accelerators and workflow agents - From CRM ecosystems and commercial platforms to implementation timelines and operational complexity, this is a sharp look at how organizations can rethink efficiency without rebuilding everything from scratch. A relevant watch for leaders across pharma, biotech, commercial operations, technology, and digital transformation. #Pharma #Biotech #DigitalTransformation #LifeSciences #CommercialOperations #EnterpriseTechnology #WorkflowAutomation #AIinPharma #Improzo

Video Content